|
Kenji Yasukawa, Ph.D.
Representative Director,
President and Chief Executive Officer (CEO)
Division in charge: Corporate Advocacy & Relations, External Relations, Healthcare Policy, Internal Audit, Sustainability
|
|
Naoki Okamura
Representative Director, Executive Vice President,
Chief Strategy Officer (CStO)
Division in charge: Advanced Informatics and Analytics, Business Development, Corporate Strategy, Information Systems, iota Biosciences, Patient Centricity, Primary Focus Lead Blindness & Beyond, Primary Focus Lead Genetic Regulation, Primary Focus Lead Immune Homeostasis, Primary Focus Lead Immuno-Oncology, Primary Focus Lead Mitochondria, Rx+ Business Accelerator, Transformation Office
|
|
Fumiaki Sakurai
Chief Administrative Officer (CAO) and Chief Ethics & Compliance Officer (CECO)
Division in charge: Corporate Risk Management, Ethics & Compliance, Executive Office, Human Resources
|
|
Bernhardt Zeiher, M.D.
Chief Medical Officer (CMO)
Division in charge: Development, Medical Affairs, M&D Strategy & Operations, Pharmacovigilance, Quality Assurance, Regulatory Affairs
|
|
Yukio Matsui
Chief Commercial Officer (CCO)
Division in charge: Established Markets Commercial, Gene Therapy Commercial, Greater China Commercial, International Markets Commercial, Japan Commercial, United States Commercial, Commercial Capabilities, Commercial Strategy, Market Access & Pricing, Strategic Brand Marketing Medical Specialties, Strategic Brand Marketing Oncology
|
|
Yoshitsugu Shitaka, Ph.D.
Chief Scientific Officer (CScO)
Division in charge: Affiliate Engagement, Applied Research & Operations, Discovery Accelerator, Gene Therapy Research & Technical Operations, Immuno-Oncology, Institute for Regenerative Medicine, Mitobridge, Research Architect Lead, Research Strategy & Communications, Universal Cells, Xyphos Biosciences
|
|
Minoru Kikuoka
Chief Financial Officer (CFO)
Division in charge: Finance, Procurement
|
|
Catherine Levitt
General Counsel (GC)
Division in charge: Legal
|
|
Hideki Shima
Chief Manufacturing Officer (CMfgO)
Division in charge: Pharmaceutical Technology
|